INTRODUCTION
Often the critical systems controlling cellular function are located in membrane compartments. Many of these membrane protein assemblies represent important pharmaceutical targets that have been difficult to isolate in soluble and active form because particular phospholipid environments are often essential for maintaining optimal enzymatic turnover or receptor binding activity. Several pharmacologically significant examples indicate specific phospholipid requirements for individual enzymes and receptors, which are perturbed by detergents typically used to solubilize membrane proteins. Examples include the human β-adrenergic receptor, which requires neutral lipids for efficient receptor hormone response (1) , and the human cytochrome P450 monooxygenase (P450) superfamily, which requires several phospholipid types for efficient drug metabolism (2) . An inability to faithfully reconstitute the lipid requirements of detergent-solubilized protein in purified systems can, and often does, affect the measured activity of these enzymes. One of the most widely used alternatives for characterization of these native proteins involves the subfractionation of natural cellular membranes and incorporation into micron-sized liposomes. However, liposomes are compromised by thermodynamic instability, size heterogeneity, and sequestration of target membrane proteins on the solvent-inaccessible side of the bilayer (3, 4) . Other convenient methods for obtaining large quantities of soluble functional membrane proteins assembled in phospholipid bilayers have not been available, and as a consequence, our molecular understanding of the numerous protein complexes functioning within cell membranes has been hindered. Here we report a rapid method for compartmentalizing heterologously expressed membrane proteins into stable soluble nanometer-scale bilayer structures that avoid many of these previously described limitations. The key to our described self-as- allows for structural plasticity in the formation of the more common spherical form of the human lipoproteins (5), we synthesized a truncated form of apoA-I, termed MSP, that is idealized for bacterial expression, purification, and self-assembly of discoidal lipid nanobilayers (Nanodiscs) (9) . MSP is a synthetic gene containing 200 amino acid residues arranged in amphipathic helices and an N-terminal His 6 -Factor X tag sequence. We reasoned that this Nanodisc system could provide a simple and ideal means for high-throughput solubilization and analysis of heterologously expressed membrane proteins, if these proteins could be directly incorporated into Nanodiscs without the need for prepurification of the target. Here we report the methodologies for transferring membrane-bound proteins directly from partially fractionated cellular membranes into soluble nanostructures.
To demonstrate this assembly process using heterologously expressed membrane proteins, Spodoptera frugiperda (Sf9) insect cells were transfected with a recombinant baculovirus construct containing cDNA sequences for our target membrane protein. The particular protein chosen for this analysis was CYP6B1, a P450 isolated from the black swallowtail (Papilio polyxenes), which is responsible for this insect's ability to bind and detoxify plant psoralen derivatives encountered in its environment (10, 11) . The spectral properties of this and other P450s are optimal for monitoring the assembly of functional MSP-protein complexes, because they allow the concentration and integrity of the CYP6B1 target protein to be readily followed throughout the solubilization and fractionation procedures (12) . The self-assembly process described below indicates that this heterologously expressed P450 protein can be effectively dispersed into soluble nanoscale lipid bilayer cassettes, sizefractionated, and arrayed in a format suitable for high-throughput analysis of substrate binding.
MATERIALS AND METHODS

Protein Expression and Purification
Expression and purification of MSP was carried out as previously described (9).
Preparation of Microsomes
Construction of the recombinant CYP6B1 baculovirus expression vector and infection of Sf9 was performed as previously described (10) . Typically, 32 plates containing 6 × 10 7 baculovirus-infected cells each [multiplicity of infection (MOI) of 2] were collected 72 h postinfection. Microsomal membranes were homogenized in 2 mL grinding buffer (pH 7.8) composed of 0.1 M sodium phosphate buffer, pH 7.8, 1.1 mM EDTA, 20% glycerol, 0.5 mM phenylmethylsulfonyl fluoride (PMSF), 0.1 mM dithiothreitol (DTT), and 5 µg/mL (w/v) leupeptin. Membranes were frozen in liquid nitrogen and stored at -80°C.
Nanodisc Assembly
The lipid concentration of the membranes was determined using a BCA™ protein assay kit (Pierce Chemical, Rockford, IL, USA) and a 1:1 mass relationship of protein/lipid in the membranes. The membranes were detergent-solubilized with 0.5 M cholic acid and mixed with MSP in the approximate ratio of 1: 100:200 for MSP/lipid/detergent. Typically, reconstitution samples included approximately 100 nmol scaffold protein, 10 µmol lipid, and 20 µmol cholate and were pre-incubated for 1.5 h at 4°C. Detergent was removed by incubating with Bio-Beads ® SM-2 Adsorbent from (BioRad Laboratories, Hercules, CA, USA) (approximately 0.4 g Bio-Beads/1 mL reconstitution mixture) for 1.5 h at 4°C followed by centrifugation at 11,750× g for 5 min. His 6 -tagged MSP particles were purified by incubating with 1 mL of Ni-NTA agarose (Qiagen, Valencia, CA, USA) per 7.5 g of His 6 -tagged MSP for 1 h at 4°C, followed by centrifugation at 11,750× g for 5 min. MSP particles bound to the Ni-NTA agarose were washed with three sequential resin volumes of 0.1 M sodium phosphate buffer (pH 7.4) containing 0.3 M NaCl, 0.15 M NaCl, and no NaCl, respectively. To maintain the integrity of the CYP6B1 protein, MSP particles were eluted with 0.1 M sodium phosphate buffer (pH 7.4) containing 0.25 M EDTA rather than the 50 mM imidazole used in previous MSP purifications.
Gel Electrophoresis
For sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), microliter samples were separated on PhastGel Gradient 8-25 (Amersham Biosciences, Piscataway, NJ, USA) and stained with Coomassie ® Brilliant Blue. 
RESEARCH REPORT
Sizing Column Purification
The nickel affinity-purified sample mixture was injected onto a Superdex™ 200 HR10/30 gel filtration column (Amersham Biosciences) equilibrated in 0.1 M sodium phosphate buffer (pH 7.4) at a flow rate of 0.5 mL/min. Fractions containing CYP6B1 were concentrated using a Centricon ® YM-30 centrifugal filter device (Millipore, Billerica, MA, USA) and reinjected onto the Superdex 200 HR10/30 gel filtration column under the same buffer conditions.
Lipid Extraction
Lipids were extracted by the Folch method (13) , where the sample was homogenized with 2:1 chloroform/methanol (v/v) and washed with one-fourth volume 0.88% KCl in water. The solution was mixed vigorously, and the phases were completely separated by centrifugation (3000× g) for 5 min. The organic layer was dried using nitrogen. The lipids were resuspended in a small amount of chloroform and stored at -20°C.
Thin-Layer Chromatography
Samples were spotted onto preparative silica gel stationary phase thin-layer chromatography (TLC) plates purchased from EMD Chemicals (Gibbstown, NJ, USA) alongside phospholipid standards purchased from Avanti (Alabaster, AL, USA) and developed using a mobile phase of chloroform/methanol/ ammonium hydroxide (65:25:4). TLC plates were exposed to iodine vapor for visualization, scanned using a ScanJet (Hewlett Packard, Palo Alto, CA, USA), and quantified on a Macintosh ® computer using the public domain National Institutes of Health (NIH) Image program developed at the NIH (available at http://rsb.info.nih.gov/nih-image/).
Substrate Binding
The CYP6B1-containing population of Nanodiscs collected after Superdex size fractionation was concentrated to an enzyme concentration of 50 nM. A microtiter plate was arranged with wells A1-A5 and B1-B5 each containing 200 µL Nanodisc samples and wells C1-C5 each containing 200 µL buffer (0.1 M sodium phosphate, pH 7.4). To rows A and C, a 20 mM stock concentration of xanthotoxin (Sigma, St. Louis, MO, USA) in methanol was added to yield final concentrations of 0 (column 1), 10 (column 2), 20 (column 3), 50 (column 4), and 150 µM (column 5). This dilution was such that the total organic solvent content did not exceed 1% when added to the Nanodisc samples. To row B, 0, 0.1, 0.2, 0.5, and 1.5 µL methanol were added. The contents of each microtiter well were scanned at 1-nm increments using a SpectraMax ® Plus microplate spectrophotometer (Molecular Devices, Sunnyvale, CA, USA) and were corrected for the background buffer absorbance (defined in row C) and Nanodisc absorbance (well A1).
RESULTS AND DISCUSSION
Assembly of Nanodiscs with Heterologously Expressed Membrane Proteins
To adapt MSP technology to a format compatible with proteomic analysis of heterologously expressed membrane proteins, membranes from Sf9 cells, overexpressing CYP6B1, were completely solubilized with detergent in the presence of the scaffold protein, MSP. Removal of the detergent using Bio-Beads initiated self-assembly, allowing for the incorporation of the membrane protein population into MSPsupported phospholipid nanobilayers, as outlined in Figure 1 . The MSP-containing particles were subsequently isolated using a nickel-chelating resin to bind the His 6 -tag on the N terminus of the scaffold protein. Analysis of the affinity-purified soluble nanobilayers by denaturing PAGE confirmed the presence of the CYP6B1 target protein as well as an array of endogenous proteins present in the original Sf9 cell membranes (Figure 2) . The nickel affinity-purified sample was fractionated by size-exclusion chromatography ( Figure 3A ) and analyzed by absorbance at 417 nm to identify a 10-nm fraction containing over 90% of the solubilized heme-containing target protein. Size-exclusion chromatography of CYP6B1-expressing Sf9 cell membranes, which were treated and fractionated in the absence of the MSP, shows that the target elutes as large nonspecific aggregates ( Figure 3A, dotted line) . The homogeneity of the MSP-supported Nanodiscs generated is dependent on the identity of lipid and its ratio of lipid to the amount of MSP used in the reconstitution procedure (9) . Our analysis of MSP disks assembled with the natural lipid pool from Sf9 insect cell membranes indicates other size populations in the initial nickel affinity-purified Nanodiscs ( Figure 3A) . These variations are due to the difficulty in determining a priori the precise concentration of MSP protein ideally matched to the lipid composition in membrane preparations expressing variable amounts of the P450 protein and to the significant size distribution of the endogenous membrane proteins that are also assembled into nanostructures in this process. These other size classes represent nonspecific aggregates that are easily separated from the approximately 10-nm diameter nanobilayer assemblies. Size-fractionated populations of Nanodiscs containing the P450 target protein are uniform and stable through refractionation on the Superdex 200 sizing column. The final CYP6B1-containing population displays a stoichiometry of approximately one CYP6B1 protein per 10 Nanodiscs ( Figure 3B ).
Lipid Composition of Nanodiscs Formed with Natural Cell Membranes
The application of MSP technology to the assembly of nanobilayers from natural biological membranes provides a unique opportunity for the direct isolation of membrane proteins from cells and their solubilization and dispersal into a system that provides a close mimic to the native cell environment. To further clarify the extent to which the phospholipid content of the isolated Nanodiscs mimics that of the original Sf9 microsomal membranes, the nickel affinity-purified and size-fractionated nanostructures assembled with Sf9 microsomal membranes were analyzed by TLC. Comparisons of these Nanodisc phospholipid populations with the major phospholipid types found in insect cell membranes, which are phosphatidylcholine, phosphatidylinositol, and phosphatidylethanolamine (14) (Figure  4 ), clearly indicates that the phospholipid composition of endogenous Sf9 microsomal membranes is preserved in assembled Nanodiscs.
Integrity of Target Membrane Protein after Nanodisc Solubilization
To determine the integrity of the membrane protein assembled into Nanodiscs, CYP6B1-containing nanostructures were assayed by reduction of the iron and binding of carbon monoxide (CO), which monitors, via an absorbance maximum at 450 nm, the quantity of protein that is intact and correctly configured for P450-mediated catalysis ( Figure 5 ) (12) . This spectral assay indicates a clear absence of absorbance at 420 nm, which is indicative of a commonly observed inactive form of the protein and documents the fact that normally labile proteins, such as P450s, are incorporated in their native form into Nanodiscs suitable for subsequent fractionation and biochemical analysis. To further demonstrate that the solubilized membrane protein is accessible for binding substrate and suitable for use in high-throughput optical analysis, the binding of xanthotoxin, one of several furanocoumarin substrates metabolized by this P450, to CYP6B1-containing Nanodiscs was analyzed in 96-well microtiter plates using a sample volume of only 200 µL Nanodiscs (10 pmol enzyme) and varying concentrations of substrate. The type-I binding spectra (15) obtained at varying concentrations of xanthotoxin ( Figure 6 ) show an absorbance shift from 420 to 390 nm that is characteristic of substrates effectively displacing water as the sixth ligand to the heme iron in the P450 catalytic site and converting the iron from low spin to high spin. These data clearly illustrate that CYP6B1's ability to bind substrate is maintained throughout the Nanodisc assembly and subsequent fractionation process.
CONCLUSION
In summary, we have described an important tool for the study of membrane protein targets as well as the complicated multicomponent assemblies present in cellular bilayers. When coupled with our ability to express individual cloned P450s or other membrane proteins in the frequently used baculovirus, yeast, and mammalian expression systems, this technology presents the opportunity to display single membrane proteins supported in native membrane bilayers in the development of biochemical methodologies previously restricted to soluble proteins. The ability to bind substrates, inhibitors, and other interacting molecules with these solubilized membrane proteins using sensitive optical difference spectra in microtiter plates has significant potential for development of high-throughput screening methods for many different types of membrane proteins. The fact that the Nanodisc solubilization procedures may be applied nonspecifically to all membrane proteins bodes well for the development of this technology as a means for solubilization and fractionation of many pharmacological target proteins directly out of cellular membranes. Coupled with the histidine tag on the MSP molecule, this technology also presents the means to immobilize target proteins on surfaces suitable for high-throughput screening. The generation of soluble, homogeneous, and monodispersed preparations of membrane proteins incorporated into a native bilayer structure enables the techniques for structural and functional characterizations to be applied to this important class of biological macromolecules.
